SCHEMBL5744915

SCHEMBL5744915

Cc1cc(C(CN)c2cccc(Br)n2)cc2cn(COCC[Si](C)(C)C)nc12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5743215 0.91 DGAT1 (0.32) DGAT1
SCHEMBL5744724 0.86 BRD4 (0.32) —
SCHEMBL5746724 0.85 DGAT1 (0.32) DGAT1
SCHEMBL5744596 0.85 ALOX5 (0.30) —
SCHEMBL5745800 0.83 DGAT1 (0.32) DGAT1
SCHEMBL4501118 0.82 DGAT1 (0.32) DGAT1
SCHEMBL4497086 0.81 DGAT1 (0.32) DGAT1
SCHEMBL5744102 0.78 — —
SCHEMBL5745667 0.77 BRD4 (0.34) DGAT1
SCHEMBL5745077 0.75 PDE10A (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689738-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS Bristol-Myers Squibb Company (US) 2006-08-16 — — EP disclosed
WO-2005056550-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-23 — — WO disclosed
Send feedback